{"id":124623,"date":"2024-05-22T13:08:07","date_gmt":"2024-05-22T07:38:07","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=124623"},"modified":"2024-05-22T13:20:36","modified_gmt":"2024-05-22T07:50:36","slug":"pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/","title":{"rendered":"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2113954626\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1493233154\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>At 12:15 p.m., <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/MOREPENLAB\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Morepen Laboratories Ltd<\/a><\/strong> shares were trading at \u20b950.60 per share, up 6.19% on the Bombay Stock Exchange from the previous close price. The company has a market capitalization of \u20b92,586 crore.\u00a0<\/p><p><strong>As per the company\u2019s filing, Profit After Tax (PAT) for Q4 FY24 stood at \u20b9 28.74 crores, representing a 249% increase from \u20b9 8.24 crores in the same period last year. On an annual basis, PAT rose by 150% to \u20b9 96.62 crores from \u20b9 38.68 crores in FY23. Earnings Per Share (EPS) increased from \u20b9 0.77 to \u20b9 1.88 for FY24.\u00a0<\/strong><\/p><p>Revenue from operations for Q4 FY24 amounted to \u20b9 423 crores, reflecting a 14% growth compared to \u20b9 363 crores in the same period last year.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2711803210\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Profit Before Tax (PBT) for Q4 FY24 was \u20b9 42.20 crores, a substantial increase of 279% from \u20b9 11.14 crores in Q4 FY23. Annually, PBT grew by 143% to \u20b9 135.42 crores from \u20b9 55.76 crores in FY23.&nbsp;<\/p><p>Annual revenue for FY24 was \u20b91,704 crores, marking a notable 20% increase from \u20b91,424 crores in FY23. EBITDA for Q4 FY24 surged by 182% to \u20b952.62 crores, compared to \u20b918.68 crores in the same quarter last year.&nbsp;<\/p><p>For the entire fiscal year, EBITDA doubled, reaching \u20b9172.60 crores, up 101% from \u20b985.67 crores in FY23. Meanwhile, profit for FY24 was \u20b996.62 crores, representing a 150% increase compared to \u20b938.68 crores in FY23.&nbsp;<\/p><p>Morepen Laboratories Ltd. is a leading pharmaceutical company in India that specializes in the manufacturing and supply of bulk drugs, formulations, diagnostics, and APIs.&nbsp;<\/p><p>The company exports a substantial portion of its API products, catering to the needs of numerous international markets. Morepen holds a leadership position in the export of 6 key API products,Loratadine, Montelukast, Desloratadine, Atorvastatin and Fexofenadine.<\/p><p>The company&#8217;s API segment experienced a remarkable 32% increase in exports to the US market and impressive growth rates of up to 53% across multiple continents. Despite significant price pressures, the API business achieved a commendable 14% growth in revenue and a 39% growth in volume, with 68% of its revenue coming from international markets, serving over 500 customers worldwide.&nbsp;<\/p><div class=\"trade-content-10\" id=\"trade-1051434871\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>Shares of Morepen Laboratories Ltd have risen by 16% over the past six months and by 97% over the past year.&nbsp;<\/p><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong>Written by Omkar Chitnis&nbsp;<\/strong><\/p><\/blockquote><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-after-content\" id=\"trade-334651218\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.&nbsp; At 12:15 p.m., Morepen Laboratories Ltd shares were trading at \u20b950.60 per share, up 6.19% on the Bombay Stock Exchange from the previous close price. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":111747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[18384,16864,18385,14660,948,936,3157],"class_list":["post-124623","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-morepen-laboratories","tag-morepen-laboratories-latest-news","tag-morepen-laboratories-result","tag-morepen-laboratories-share-price","tag-stock-market","tag-stock-market-news","tag-stock-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4 - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4\" \/>\n<meta property=\"og:description\" content=\"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T07:38:07+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-22T07:50:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/\",\"url\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/\",\"name\":\"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4 - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"datePublished\":\"2024-05-22T07:38:07+00:00\",\"dateModified\":\"2024-05-22T07:50:36+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4 - Trade Brains Features","description":"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/","og_locale":"en_US","og_type":"article","og_title":"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4","og_description":"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2024-05-22T07:38:07+00:00","article_modified_time":"2024-05-22T07:50:36+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/","url":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/","name":"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4 - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","datePublished":"2024-05-22T07:38:07+00:00","dateModified":"2024-05-22T07:50:36+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"The shares of a leading pharmaceutical producer of active pharmaceutical ingredients and formulations rose by 9.5% to \u20b952.20 per share after the company reported a net profit growth of 249%.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/10\/pharma03.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/pharma-stock-under-50-jumps-9-after-company-announces-net-profit-increase-by-249-in-q4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Pharma stock under \u20b9 50 jumps 9% after company announces net profit increase of 249% in Q4"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=124623"}],"version-history":[{"count":2,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124623\/revisions"}],"predecessor-version":[{"id":124630,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/124623\/revisions\/124630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/111747"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=124623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=124623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=124623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}